series-c-plus
Stage
1
Investors
About
Gracell is a global clinical-stage biopharmaceutical company developing next-generation CAR-T cell therapies for cancer and autoimmune diseases using innovative platforms like FasTCART, TruUCART, and SMART CART to improve efficacy and accessibility.
Explore Gracell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.